Liver Diseases  >>  Asclevir (ravidasvir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Asclevir (ravidasvir) / Presidio Pharma, Ascletis, Pharco Pharmaceuticals
NCT01448200: A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

Checkmark HCV infection in genotype 1 patients
Mar 2013 - Mar 2013: HCV infection in genotype 1 patients
Checkmark
Dec 2012 - Dec 2012: 
Completed
1
82
US, RoW
PPI-668, Placebo
Presidio Pharmaceuticals, Inc.
Hepatitis C, Chronic
11/12
11/12

Download Options